In this issue there is a State-of-the-Art on the management of in-stent restenosis, the most common cause of stent failure after PCI today. A mini focus on drug-eluting stents (DES) and drug-coated balloons (DCB), with articles on polymer-free vs polymer DES from the SORT OUT IX trial; the BIOVITESSE study looking at the BIOrapid polymer-free coated coronary stent system which could be used with shorter DAPT; differences in coronary vasomotion between DES vs DCB. In coronary interventions: the impact of OCT use in determining suboptimal criteria for stent implantation from the CLI-OPCI registry. In valvular disease and heart failure: the challenge of cerebral embolisation during transcatheter edge-to-edge repair (TEER) of the mitral valve using the MitraClip system; employing the leaflet-to-annulus index to predicting residual tricuspid regurgitation after TEER; and more...
Kawai T, Watanabe T, Yamada T, Morita T, Furukawa Y, Tamaki S, Kawasaki M, Kikuchi A, Seo M, Nakamura J, Tachibana K, Kida H, Sotomi Y, Sakata Y, Fukunami M
Prati F, Romagnoli E, Biccirè F, Burzotta F, La Manna A, Budassi S, Ramazzotti V, Albertucci M, Fabbiocchi F, Sticchi A, Trani C, Calligaris G, Fineschi M, Versaci F, Tamburino C, Ozaki Y, Alfonso F, Mintz GS